Hepato-pancreato-biliary

Caring At It's best
Home » Our teams » Medical » Surgery » Hepato-pancreato-biliary

Hepato-pancreato-biliary

Service Our hepato-pancreato-biliary (HPB) unit includes a multi-disciplinary team and services over two and a half million patients. We offer a level one primary HPB cancer unit (as defined by the new HPB cancer measures). Our services include laparoscopic/open (robotic) surgical resections, ablation procedures, palliative bypasses, nuclear medicine treatment and percutaneous interventional procedures (such as […]

Service

Our hepato-pancreato-biliary (HPB) unit includes a multi-disciplinary team and services over two and a half million patients.

We offer a level one primary HPB cancer unit (as defined by the new HPB cancer measures).

Our services include laparoscopic/open (robotic) surgical resections, ablation procedures, palliative bypasses, nuclear medicine treatment and percutaneous interventional procedures (such as TACE, SIRT and portal vein embolisation). We undertake over 650 laparoscopic cholecystectomies and 1,000 ERCPs annually.

Our unit provides an emergency HPB service for bile duct injuries and liver trauma, and also has the largest series of total pancreatectomy and autologous islet cell transplantations in Europe.

Education

We are committed to an active education programme including fellowship teaching and teaching of foundation year doctors, undergraduates and primary care practitioners. Our teaching forms an integral part in offering HPB patients (with both benign and malignant disease) the best care possible.

Our unit provides excellent training for benign and emergency biliary disease including emergency laparoscopic cholecystectomy. It is also a high-volume cancer-resection unit undertaking over 90 pancreatic surgeries and 110 liver resections annually. It is the second largest ERCP unit in the country with the opportunity to learn how to undertake ERCP.

We are also pioneering the use of electronic resources such as smartphone apps to educate patients on pancreatic and liver cancer.

Research

We have an active academic programme in the unit, with two professors both undertaking translational and clinical research. Some of our research projects include islet cell transplantation, cancer genomics, RCTs of immunomodulatory compounds in both cancer and inflammation, ex vivo models of liver and pancreas, and chemoprevention pilot studies.

More than 20 research fellows have successfully completed MD or PhD theses with the team, and the cumulative publication record is over 500 papers in peer-reviewed journals. Our team also has collaborative links with the University of Cambridge, University of Southampton, Adelaide University and Taiwan.

More information

Find out more about us at www.HPBLeicester.com and www.facebook.com/HPBLeicester.

Life stories from UHL

View more life stories